Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $59.87 USD
Change Today +0.09 / 0.15%
Volume 438.2K
WST On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

west pharmaceutical services (WST) Snapshot

Open
$60.07
Previous Close
$59.78
Day High
$60.57
Day Low
$59.66
52 Week High
07/21/15 - $61.73
52 Week Low
08/12/14 - $39.11
Market Cap
4.3B
Average Volume 10 Days
320.2K
EPS TTM
$1.80
Shares Outstanding
71.9M
EX-Date
10/19/15
P/E TM
33.3x
Dividend
$0.48
Dividend Yield
0.73%
Current Stock Chart for WEST PHARMACEUTICAL SERVICES (WST)

Related News

No related news articles were found.

west pharmaceutical services (WST) Related Businessweek News

No Related Businessweek News Found

west pharmaceutical services (WST) Details

West Pharmaceutical Services, Inc. develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The Pharmaceutical Packaging Systems segment offers packaging components and systems for injectable drug delivery, such as stoppers and seals for vials, closures and other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. This segment also provides contract analytical laboratory services for testing and evaluating primary drug-packaging components with the contained drug formulation; and specialized testing for complete drug delivery systems. The Pharmaceutical Delivery Systems segment offers safety and administration systems, and multi-component systems for drug administration. It offers customer contract-manufacturing and assembly solutions, which include technologies, such as multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding and device assembly used to manufacture customer-owned components, as well as devices used in surgical, diagnostic, ophthalmic, other drug delivery systems, personal care, and consumer products. This segment’s administration systems comprise sterile devices for the administration of drug products, including transfer devices, needleless reconstitution systems, and vial adapters. The company sells its products primarily through its sales force and distribution network, as well as through contract sales agents and regional distributors in the United States, Germany, France, and other European countries. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

7,000 Employees
Last Reported Date: 07/30/15
Founded in 1923

west pharmaceutical services (WST) Top Compensated Officers

Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $467.0K
President of Pharmaceutical Delivery Systems
Total Annual Compensation: $350.3K
President of the Pharmaceutical Packaging Sys...
Total Annual Compensation: $346.0K
President of Pharmaceutical Packaging Systems...
Total Annual Compensation: $339.1K
Compensation as of Fiscal Year 2014.

west pharmaceutical services (WST) Key Developments

West Pharmaceutical Services, Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Half Year Ended June 30, 2015; Revised Earnings Guidance for the Year 2015

West Pharmaceutical Services, Inc. announced unaudited consolidated financial results for the second quarter and half year ended June 30, 2015. For the quarter, net sales were $359.7 million against $368.9 million a year ago. Operating profit was $39.1 million against $54.1 million a year ago. Income before income taxes was $36.1 million against $50.4 million a year ago. Net income was $27.8 million or $0.38 per diluted share against $37.6 million or $0.52 per diluted share a year ago. Adjusted operating profit was $50 million compared to $54.1 million a year ago. Adjusted profit was $34.7 million or $0.47 per diluted share. For the half year, net sales were $695.6 million against $715.7 million a year ago. Operating profit was $86.9 million against $93.4 million a year ago. Income before income taxes was $80.2 million against $86.1 million a year ago. Net income was $60.7 million or $0.83 per diluted share against $64.7 million or $0.89 per diluted share a year ago. Adjusted operating profit was $97.8 million compared to $93.4 million a year ago. Adjusted operating profit was $97.8 million. Adjusted profit was $67.6 million or $0.92 per diluted share. The company revised earrings guidance for the year 2015. Consolidated net sales are expected to be $1,400 - $1,430 million compared to prior guidance of $1,395 - $1,425 million, adjusted diluted EPS are expected to be $1.74 - $1.84 compared to prior guidance of $1.69-$1.84. EPS is expected to be between $1.65 to $1.75.

West Pharmaceutical Services, Inc. to Report Q2, 2015 Results on Jul 30, 2015

West Pharmaceutical Services, Inc. announced that they will report Q2, 2015 results at 9:00 AM, US Eastern Standard Time on Jul 30, 2015

West Pharmaceutical Services, Inc., Q2 2015 Earnings Call, Jul 30, 2015

West Pharmaceutical Services, Inc., Q2 2015 Earnings Call, Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $59.87 USD +0.09

WST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $148.46 USD +1.59
Gerresheimer AG €66.65 EUR -0.172
IDEXX Laboratories Inc $72.73 USD +1.39
Sirona Dental Systems Inc $103.78 USD +1.01
STERIS Corp $69.13 USD +0.44
View Industry Companies
 

Industry Analysis

WST

Industry Average

Valuation WST Industry Range
Price/Earnings 32.9x
Price/Sales 3.0x
Price/Book 4.6x
Price/Cash Flow 32.4x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit www.westpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.